These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

750 related items for PubMed ID: 10225452

  • 1. Recognition of breast cancer-associated peptides by tumor-reactive, HLA-class I restricted allogeneic cytotoxic T lymphocytes.
    Nguyen T, Naziruddin B, Dintzis S, Doherty GM, Mohanakumar T.
    Int J Cancer; 1999 May 17; 81(4):607-15. PubMed ID: 10225452
    [Abstract] [Full Text] [Related]

  • 2. Evidence for cytotoxic T lymphocyte response against human lung cancer: reconstitution of antigenic epitope with peptide eluted from lung adenocarcinoma MHC class I.
    Calhoun RF, Naziruddin B, Enriquez-Rincon F, Duffy BF, Ritter JM, Sundaresan S, Patterson GA, Cooper JD, Mohanakumar T.
    Surgery; 2000 Jul 17; 128(1):76-85. PubMed ID: 10876189
    [Abstract] [Full Text] [Related]

  • 3. Tumor associated antigens in human renal cell carcinoma: MHC restricted recognition by cytotoxic T lymphocytes.
    Bernhard H, Jäger E, Maeurer MJ, Meyer zum Büschenfelde KH, Knuth A.
    Tissue Antigens; 1996 Jul 17; 48(1):22-31. PubMed ID: 8864171
    [Abstract] [Full Text] [Related]

  • 4. Tumor specific cytolysis by tumor infiltrating lymphocytes in breast cancer.
    Baxevanis CN, Dedoussis GV, Papadopoulos NG, Missitzis I, Stathopoulos GP, Papamichail M.
    Cancer; 1994 Aug 15; 74(4):1275-82. PubMed ID: 7914469
    [Abstract] [Full Text] [Related]

  • 5. Human Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes home preferentially to and induce selective regressions of autologous EBV-induced B cell lymphoproliferations in xenografted C.B-17 scid/scid mice.
    Lacerda JF, Ladanyi M, Louie DC, Fernandez JM, Papadopoulos EB, O'Reilly RJ.
    J Exp Med; 1996 Mar 01; 183(3):1215-28. PubMed ID: 8642263
    [Abstract] [Full Text] [Related]

  • 6. HLA restriction and T-cell-receptor V beta gene expression of cytotoxic T lymphocytes reactive with human squamous-cell carcinoma of the head and neck.
    Yasumura S, Weidmann E, Hirabayashi H, Johnson JT, Herberman RB, Whiteside TL.
    Int J Cancer; 1994 May 01; 57(3):297-305. PubMed ID: 8168988
    [Abstract] [Full Text] [Related]

  • 7. Isolation of broadly reactive, tumor-specific, HLA Class-I restricted CTL from blood lymphocytes of a breast cancer patient.
    Verdegaal EM, Huinink DB, Hoogstraten C, Marijnissen AK, Gorsira MB, Claas FH, Osanto S.
    Hum Immunol; 1999 Dec 01; 60(12):1195-206. PubMed ID: 10626733
    [Abstract] [Full Text] [Related]

  • 8. HLA class-I-restricted and tumor-specific CTL in tumor-infiltrating lymphocytes of patients with gastric cancer.
    Hoshino T, Seki N, Kikuchi M, Kuramoto T, Iwamoto O, Kodama I, Koufuji K, Takeda J, Itoh K.
    Int J Cancer; 1997 Mar 17; 70(6):631-8. PubMed ID: 9096641
    [Abstract] [Full Text] [Related]

  • 9. Recognition of human renal cell carcinoma and melanoma by HLA-A2-restricted cytotoxic T lymphocytes is mediated by shared peptide epitopes and up-regulated by interferon-gamma.
    Bernhard H, Maeurer MJ, Jäger E, Wölfel T, Schneider J, Karbach J, Seliger B, Huber C, Storkus WS, Lotze MT, Meyer zum Büschenfelde KH, Knuth A.
    Scand J Immunol; 1996 Sep 17; 44(3):285-92. PubMed ID: 8795723
    [Abstract] [Full Text] [Related]

  • 10. MHC-restricted recognition of autologous melanoma by tumor-specific cytotoxic T cells. Evidence for restriction by a dominant HLA-A allele.
    Crowley NJ, Darrow TL, Quinn-Allen MA, Seigler HF.
    J Immunol; 1991 Mar 01; 146(5):1692-9. PubMed ID: 1671580
    [Abstract] [Full Text] [Related]

  • 11. Cellular immune response to human renal-cell carcinomas: definition of a common antigen recognized by HLA-A2-restricted cytotoxic T-lymphocyte (CTL) clones.
    Bernhard H, Karbach J, Wölfel T, Busch P, Störkel S, Stöckle M, Wölfel C, Seliger B, Huber C, Meyer zum Büschenfelde KH.
    Int J Cancer; 1994 Dec 15; 59(6):837-42. PubMed ID: 7989126
    [Abstract] [Full Text] [Related]

  • 12. Lysis of CD4+ lymphocytes by non-HLA-restricted cytotoxic T lymphocytes from HIV-infected individuals.
    Grant MD, Smaill FM, Rosenthal KL.
    Clin Exp Immunol; 1993 Sep 15; 93(3):356-62. PubMed ID: 8103717
    [Abstract] [Full Text] [Related]

  • 13. Detection of naturally processed and HLA-A1-presented melanoma T-cell epitopes defined by CD8(+) T-cells' release of granulocyte-macrophage colony-stimulating factor but not by cytolysis.
    Maeurer MJ, Martin D, Elder E, Storkus WJ, Lotze MT.
    Clin Cancer Res; 1996 Jan 15; 2(1):87-95. PubMed ID: 9816095
    [Abstract] [Full Text] [Related]

  • 14. Screening of HLA-A24-restricted epitope peptides from prostate-specific membrane antigen that induce specific antitumor cytotoxic T lymphocytes.
    Horiguchi Y, Nukaya I, Okazawa K, Kawashima I, Fikes J, Sette A, Tachibana M, Takesako K, Murai M.
    Clin Cancer Res; 2002 Dec 15; 8(12):3885-92. PubMed ID: 12473604
    [Abstract] [Full Text] [Related]

  • 15. Overlapping epitopes that are recognized by CD8+ HLA class I-restricted and CD4+ class II-restricted cytotoxic T lymphocytes are contained within an influenza nucleoprotein peptide.
    Carreno BM, Turner RV, Biddison WE, Coligan JE.
    J Immunol; 1992 Feb 01; 148(3):894-9. PubMed ID: 1370522
    [Abstract] [Full Text] [Related]

  • 16. Human immune responses to porcine endogenous retrovirus-derived peptides presented naturally in the context of porcine and human major histocompatibility complex class I molecules: implications in xenotransplantation of porcine organs.
    Ramachandran S, Jaramillo A, Xu XC, McKane BW, Chapman WC, Mohanakumar T.
    Transplantation; 2004 May 27; 77(10):1580-8. PubMed ID: 15239626
    [Abstract] [Full Text] [Related]

  • 17. Tumour-specific CTL response requiring interactions of four different cell types and recognition of MHC class I and class II restricted tumour antigens.
    Schirrmacher V, Schild HJ, Gückel B, von Hoegen P.
    Immunol Cell Biol; 1993 Aug 27; 71 ( Pt 4)():311-26. PubMed ID: 7901150
    [Abstract] [Full Text] [Related]

  • 18. CD4(+), HLA class I-restricted, cytolytic T-lymphocyte clone against primary malignant melanoma cells.
    Somasundaram R, Robbins P, Moonka D, Loh E, Marincola F, Patel A, Guerry D, Herlyn D.
    Int J Cancer; 2000 Jan 15; 85(2):253-9. PubMed ID: 10629086
    [Abstract] [Full Text] [Related]

  • 19. Identification of MHC class II restricted T-cell-mediated reactivity against MHC class I binding Mycobacterium tuberculosis peptides.
    Wang M, Tang ST, Stryhn A, Justesen S, Larsen MV, Dziegiel MH, Lewinsohn DM, Buus S, Lund O, Claesson MH.
    Immunology; 2011 Apr 15; 132(4):482-91. PubMed ID: 21294723
    [Abstract] [Full Text] [Related]

  • 20. Detection of melanoma-reactive CD4+ HLA-class I-restricted cytotoxic T cell clones with long-term assay and pretreatment of targets with interferon-gamma.
    LeMay LG, Kan-Mitchell J, Goedegebuure P, Harel W, Mitchell MS.
    Cancer Immunol Immunother; 1993 Aug 15; 37(3):187-94. PubMed ID: 8101473
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.